Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002024694 | SCV002317397 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004046963 | SCV003715942 | uncertain significance | not specified | 2022-05-31 | criteria provided, single submitter | clinical testing | The c.602G>A (p.R201H) alteration is located in exon 3 (coding exon 3) of the OAS1 gene. This alteration results from a G to A substitution at nucleotide position 602, causing the arginine (R) at amino acid position 201 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |